---
input_text: 'Re-evaluation of King Wilson Index in Children With Acutely Decompensated
  Hepatic Wilson Disease. OBJECTIVES: Liver transplantation (LT) in Wilson disease
  (WD) is a life-saving option for patients presenting with liver failure and encephalopathy.
  Patients without encephalopathy can avoid LT and treated successfully with chelation
  therapy. It is essential to predict the risk of fatal outcomes where LT is required.
  We aim to critically analyse the validity of the WD Index prospectively from a cohort
  of WD patients managed at our institution. METHODS: WD Index and other clinical
  data from 2005 to 2018, recorded prospectively as part of clinical management, were
  analysed. RESULTS: Over 13-year period, 52 children with WD (29 boys) with median
  age at diagnosis of 11.69 (range 3.92-17.26) years were studied. Of these, 17 were
  diagnosed as part of family screening, 17 presented with abnormal liver enzyme,
  and 18 with acute hepatic decompensation (AHD) as per PALF definition. Patients
  presented with abnormal liver enzyme and in the pre-symptomatic group had WD Index
  <11, and none of them required LT. WD Index is still a good predictor for LT in
  WD patients with AHD, providing a sensitivity of 80%, specificity of 100%, positive-predictive,
  and negative-predictive value of 100% and 80%, respectively. Patients presented
  with an index of 8-10 also required LT at median duration of 58 days (IQR 48-135
  days). CONCLUSIONS: WD patients presenting with AHD who had an index of >=11 do
  require LT. Children with a WD Index of 8 to 10 within the first 2 months of admission
  require close monitoring as LT may become necessary.'
raw_completion_output: |-
  primary_disease: Acutely Decompensated Hepatic Wilson Disease

  medical_actions: Liver transplantation (LT); Chelation therapy; Clinical management; Close monitoring

  symptoms: Liver failure; Encephalopathy; Abnormal liver enzyme; Acute hepatic decompensation (AHD)

  chemicals: 

  action_annotation_relationships: Liver transplantation (LT) TREATS liver failure IN Acutely Decompensated Hepatic Wilson Disease; Liver transplantation (LT) TREATS encephalopathy IN Acutely Decompensated Hepatic Wilson Disease; Chelation therapy TREATS Acutely Decompensated Hepatic Wilson Disease IN patients without encephalopathy; Close monitoring TREATS Acutely Decompensated Hepatic Wilson Disease IN Children with a WD Index of 8 to 10
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Close monitoring TREATS Acutely Decompensated Hepatic Wilson Disease IN Children with a WD Index of 8 to 10

  ===

extracted_object:
  primary_disease: Acutely Decompensated Hepatic Wilson Disease
  medical_actions:
    - MAXO:0001175
    - Chelation therapy
    - Clinical management
    - Close monitoring
  symptoms:
    - HP:0001399
    - HP:0001298
    - Abnormal liver enzyme
    - Acute hepatic decompensation (AHD)
  action_annotation_relationships:
    - subject: MAXO:0001175
      predicate: TREATS
      object: HP:0001399
      qualifier: Acutely Decompensated Hepatic Wilson Disease
    - subject: <Liver transplantation>
      predicate: <TREATS>
      object: <encephalopathy>
      qualifier: <Acutely Decompensated Hepatic Wilson Disease>
      subject_qualifier: <N/A>
      object_qualifier: <N/A>
      subject_extension: <Liver transplantation>
      object_extension: <N/A>
    - subject: <Chelation therapy>
      predicate: <TREATS>
      object: <Acutely Decompensated Hepatic Wilson Disease>
      qualifier: <without encephalopathy>
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <Chelation>
      object_extension: <>
    - subject: <Close monitoring>
      predicate: <TREATS>
      object: <Acutely Decompensated Hepatic Wilson Disease>
      qualifier: <Children with a WD Index of 8 to 10>
      subject_qualifier: <None>
      object_qualifier: <None>
      subject_extension: <None>
      object_extension: <None>
named_entities:
  - id: MONDO:0010200
    label: Wilson's disease
  - id: MAXO:0001175
    label: liver transplantation
  - id: HP:0001695
    label: cardiac arrest
  - id: HP:0001685
    label: myocardial fibrosis
  - id: HP:0001663
    label: ventricular fibrillation
  - id: CHEBI:30703
    label: tetrathiomolybdate (TTM)
  - id: CHEBI:35176
    label: Zinc sulphate
  - id: CHEBI:35475
    label: NSAIDs
  - id: MAXO:0001001
    label: Gene therapy
  - id: HP:0006554
    label: acute liver failure
  - id: HP:0003256
    label: coagulopathy
  - id: HP:0002480
    label: hepatic encephalopathy
  - id: HP:0001337
    label: Tremor
  - id: HP:0001332
    label: Dystonia
  - id: CHEBI:28694
    label: Copper
  - id: HP:0001395
    label: Liver fibrosis
  - id: HP:0001394
    label: Cirrhosis
  - id: CHEBI:39501
    label: trientine
  - id: CHEBI:27363
    label: zinc
  - id: HP:0001410
    label: hepatic dysfunction
  - id: CHEBI:7959
    label: D-penicillamine
  - id: MAXO:0000376
    label: Liver biopsy
  - id: HP:0001404
    label: Hepatocellular necrosis
  - id: CHEBI:61049
    label: Tacrolimus
  - id: CHEBI:50868
    label: Penicillamine
  - id: HP:0001744
    label: splenomegaly
  - id: HP:0001541
    label: ascites
  - id: HP:0001260
    label: Dysarthria
  - id: HP:0001347
    label: Hyperreflexia
  - id: HP:0031843
    label: Bradyphrenia
  - id: HP:0002362
    label: Shuffling gait
  - id: HP:0002300
    label: Mutism
  - id: HP:0001621
    label: Hypophonia
  - id: CHEBI:37153
    label: Calcineurin inhibitors
  - id: CHEBI:8356
    label: Pramipexole
  - id: CHEBI:2618
    label: Amantadine
  - id: HP:0001399
    label: liver failure
  - id: HP:0000952
    label: jaundice
  - id: HP:0001919
    label: acute kidney injury
  - id: HP:0200032
    label: Kayser-Fleischer rings
  - id: MONDO:0013792
    label: Intracerebral Hemorrhage
  - id: HP:0001342
    label: Intracerebral Hemorrhage
  - id: MAXO:0000533
    label: Molecular genetic testing
  - id: HP:0001873
    label: thrombocytopenia
  - id: HP:0002344
    label: worsening neurological symptoms
  - id: HP:0001272
    label: Cerebellar Atrophy
  - id: HP:0012896
    label: abnormal motor evoked potentials (MEPs)
  - id: HP:0001392
    label: liver disease
  - id: HP:0001396
    label: cholestasis
  - id: HP:0001403
    label: macrovesicular steatosis
  - id: CHEBI:8830
    label: rhodanine
  - id: CHEBI:90299
    label: orcein
  - id: MONDO:0018874
    label: Acute Myeloid Leukemia (t-AML or AML-MRC)
  - id: CHEBI:41977
    label: Daunorubicin
  - id: CHEBI:28680
    label: Cytarabine
  - id: CHEBI:37404
    label: Elemental copper
  - id: CHEBI:16856
    label: Plasma glutathione (GSH)
  - id: CHEBI:53498
    label: Total antioxidant capacity (TAC)
  - id: CHEBI:566274
    label: Malondialdehyde (MDA)
  - id: CHEBI:33697
    label: RNAs
  - id: HP:0000989
    label: itchy skin
  - id: CHEBI:63623
    label: Dimercaptosuccinic acid
  - id: CHEBI:145810
    label: insulin
  - id: HP:0001250
    label: Epileptic seizures
  - id: HP:0001298
    label: Encephalopathy
  - id: HP:0002315
    label: Headache
  - id: CHEBI:6437
    label: Levetiracetam
  - id: HP:0002878
    label: Acute respiratory failure
  - id: CHEBI:166831
    label: copper chelating agents
  - id: MONDO:0004789
    label: Cholangitis
  - id: MAXO:0010026
    label: zinc supplementation
  - id: CHEBI:16796
    label: Melatonin
  - id: MAXO:0009095
    label: Zinc (Zn) therapy
  - id: MAXO:0001298
    label: therapy
  - id: CHEBI:38161
    label: Chelator
  - id: MONDO:0019542
    label: Acute Liver Failure (ALF)
  - id: HP:0002204
    label: Pulmonary embolism
  - id: HP:0100806
    label: Sepsis
  - id: HP:0001944
    label: dehydration
  - id: CHEBI:18248
    label: iron
  - id: CHEBI:18291
    label: manganese
  - id: CHEBI:22984
    label: calcium
  - id: HP:0001081
    label: Cholelithiasis
  - id: HP:0002716
    label: Lymphadenopathy
  - id: MONDO:0100193
    label: End-stage liver diseases
  - id: HP:0002040
    label: Esophageal varices
  - id: HP:0100626
    label: End-stage liver diseases
  - id: MONDO:0017014
    label: children
  - id: MAXO:0009016
    label: Botulinum toxin type A (BoNT-A) injection
  - id: CHEBI:3160
    label: Botulinum toxin type A (BoNT-A)
  - id: HP:0003088
    label: Premature osteoarthritis
  - id: HP:0002885
    label: Mallory-Denk body (MDB) formation
  - id: CHEBI:35341
    label: Steroids
  - id: CHEBI:16990
    label: Bilirubin
  - id: MONDO:0100192
    label: Liver failure
  - id: HP:0001409
    label: Portal hypertension
  - id: HP:0001402
    label: Hepatocellular carcinoma
  - id: CHEBI:30663
    label: Serum ceruloplasmin (CP)
  - id: HP:0001513
    label: obesity
  - id: CHEBI:16610
    label: spermidine
  - id: CHEBI:27881
    label: resveratrol
  - id: CHEBI:15351
    label: AcCoA
